272 related articles for article (PubMed ID: 32427590)
1. MUC1-C drives stemness in progression of colitis to colorectal cancer.
Li W; Zhang N; Jin C; Long MD; Rajabi H; Yasumizu Y; Fushimi A; Yamashita N; Hagiwara M; Zheng R; Wang J; Kui L; Singh H; Kharbanda S; Hu Q; Liu S; Kufe D
JCI Insight; 2020 Jun; 5(12):. PubMed ID: 32427590
[TBL] [Abstract][Full Text] [Related]
2. MUC1-C regulates lineage plasticity driving progression to neuroendocrine prostate cancer.
Yasumizu Y; Rajabi H; Jin C; Hata T; Pitroda S; Long MD; Hagiwara M; Li W; Hu Q; Liu S; Yamashita N; Fushimi A; Kui L; Samur M; Yamamoto M; Zhang Y; Zhang N; Hong D; Maeda T; Kosaka T; Wong KK; Oya M; Kufe D
Nat Commun; 2020 Jan; 11(1):338. PubMed ID: 31953400
[TBL] [Abstract][Full Text] [Related]
3. MUC1-C Activates the BAF (mSWI/SNF) Complex in Prostate Cancer Stem Cells.
Hagiwara M; Yasumizu Y; Yamashita N; Rajabi H; Fushimi A; Long MD; Li W; Bhattacharya A; Ahmad R; Oya M; Liu S; Kufe D
Cancer Res; 2021 Feb; 81(4):1111-1122. PubMed ID: 33323379
[TBL] [Abstract][Full Text] [Related]
4. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.
Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW
Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932
[TBL] [Abstract][Full Text] [Related]
5. Significance of Lgr5(+ve) cancer stem cells in the colon and rectum.
Takahashi H; Ishii H; Nishida N; Takemasa I; Mizushima T; Ikeda M; Yokobori T; Mimori K; Yamamoto H; Sekimoto M; Doki Y; Mori M
Ann Surg Oncol; 2011 Apr; 18(4):1166-74. PubMed ID: 21125339
[TBL] [Abstract][Full Text] [Related]
6. NHE8 Deficiency Promotes Colitis-Associated Cancer in Mice via Expansion of Lgr5-Expressing Cells.
Xu H; Li J; Chen H; Ghishan FK
Cell Mol Gastroenterol Hepatol; 2019; 7(1):19-31. PubMed ID: 30465020
[TBL] [Abstract][Full Text] [Related]
7. Most colitis associated carcinomas lack expression of LGR5: a preliminary study with implications for unique pathways of carcinogenesis compared to sporadic colorectal carcinoma.
Iwaya M; Ota H; Nakajima T; Uehara T; Riddell R; Conner J
BMC Cancer; 2021 Feb; 21(1):119. PubMed ID: 33541282
[TBL] [Abstract][Full Text] [Related]
8. Dependence on MUC1-C in Progression of Neuroendocrine Prostate Cancer.
Kufe D
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835130
[TBL] [Abstract][Full Text] [Related]
9. MUC1-C is necessary for SHP2 activation and BRAF inhibitor resistance in BRAF(V600E) mutant colorectal cancer.
Morimoto Y; Yamashita N; Hirose H; Fushimi A; Haratake N; Daimon T; Bhattacharya A; Ahmad R; Suzuki Y; Takahashi H; Kufe DW
Cancer Lett; 2023 Apr; 559():216116. PubMed ID: 36878307
[TBL] [Abstract][Full Text] [Related]
10. MUC1-C dictates neuroendocrine lineage specification in pancreatic ductal adenocarcinomas.
Luan Z; Morimoto Y; Fushimi A; Yamashita N; Suo W; Bhattacharya A; Hagiwara M; Jin C; Kufe D
Carcinogenesis; 2022 Feb; 43(1):67-76. PubMed ID: 34657147
[TBL] [Abstract][Full Text] [Related]
11. Targeting MUC1-C Inhibits TWIST1 Signaling in Triple-Negative Breast Cancer.
Hata T; Rajabi H; Yamamoto M; Jin C; Ahmad R; Zhang Y; Kui L; Li W; Yasumizu Y; Hong D; Miyo M; Hiraki M; Maeda T; Suzuki Y; Takahashi H; Samur M; Kufe D
Mol Cancer Ther; 2019 Oct; 18(10):1744-1754. PubMed ID: 31308076
[TBL] [Abstract][Full Text] [Related]
12. LGR5 Is a Gastric Cancer Stem Cell Marker Associated with Stemness and the EMT Signature Genes NANOG, NANOGP8, PRRX1, TWIST1, and BMI1.
Wang B; Chen Q; Cao Y; Ma X; Yin C; Jia Y; Zang A; Fan W
PLoS One; 2016; 11(12):e0168904. PubMed ID: 28033430
[TBL] [Abstract][Full Text] [Related]
13. MUC1-C activates BMI1 in human cancer cells.
Hiraki M; Maeda T; Bouillez A; Alam M; Tagde A; Hinohara K; Suzuki Y; Markert T; Miyo M; Komura K; Ahmad R; Rajabi H; Kufe D
Oncogene; 2017 May; 36(20):2791-2801. PubMed ID: 27893710
[TBL] [Abstract][Full Text] [Related]
14. MUC1-C activates the PBAF chromatin remodeling complex in integrating redox balance with progression of human prostate cancer stem cells.
Hagiwara M; Fushimi A; Yamashita N; Bhattacharya A; Rajabi H; Long MD; Yasumizu Y; Oya M; Liu S; Kufe D
Oncogene; 2021 Jul; 40(30):4930-4940. PubMed ID: 34163028
[TBL] [Abstract][Full Text] [Related]
15. Leucine-rich repeat-containing G protein-coupled receptor 5 marks different cancer stem cell compartments in human Caco-2 and LoVo colon cancer lines.
Alharbi SA; Ovchinnikov DA; Wolvetang E
World J Gastroenterol; 2021 Apr; 27(15):1578-1594. PubMed ID: 33958845
[TBL] [Abstract][Full Text] [Related]
16. Lgr5+CD44+EpCAM+ Strictly Defines Cancer Stem Cells in Human Colorectal Cancer.
Leng Z; Xia Q; Chen J; Li Y; Xu J; Zhao E; Zheng H; Ai W; Dong J
Cell Physiol Biochem; 2018; 46(2):860-872. PubMed ID: 29627827
[TBL] [Abstract][Full Text] [Related]
17. MUC1-C in chronic inflammation and carcinogenesis; emergence as a target for cancer treatment.
Kufe DW
Carcinogenesis; 2020 Sep; 41(9):1173-1183. PubMed ID: 32710608
[TBL] [Abstract][Full Text] [Related]
18. Addiction of Cancer Stem Cells to MUC1-C in Triple-Negative Breast Cancer Progression.
Yamashita N; Kufe D
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897789
[TBL] [Abstract][Full Text] [Related]
19. MUC1-C activates the TAK1 inflammatory pathway in colon cancer.
Takahashi H; Jin C; Rajabi H; Pitroda S; Alam M; Ahmad R; Raina D; Hasegawa M; Suzuki Y; Tagde A; Bronson RT; Weichselbaum R; Kufe D
Oncogene; 2015 Oct; 34(40):5187-97. PubMed ID: 25659581
[TBL] [Abstract][Full Text] [Related]
20. MUC1-C Dictates JUN and BAF-Mediated Chromatin Remodeling at Enhancer Signatures in Cancer Stem Cells.
Bhattacharya A; Fushimi A; Yamashita N; Hagiwara M; Morimoto Y; Rajabi H; Long MD; Abdulla M; Ahmad R; Street K; Liu S; Liu T; Kufe D
Mol Cancer Res; 2022 Apr; 20(4):556-567. PubMed ID: 35022313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
